Shilpa Medicare Share Price (SHILPAMED)
Check the latest share price of Shilpa Medicare, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
₹901.4
▲0.99%
as on 04:01PM, 30 May 2025
NSE
Shilpa Medicare Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹889.2Day's Price Range₹924.252 Week's Low
52 Week's High
₹417.652-Week Price Range₹959.5
| Returns % | |
| 1 Month Return | + 42.98 % |
| 3 Month Return | + 49.32 % |
| 1 Year Return | + 85.63 % |
| 3 Year Return | + 107.5 % |
| 5 Year Return | + 128.99 % |
| Market Stats | |
| Previous Close | ₹892.60 |
| Open | ₹892.10 |
| Volume | 5.79L |
| Upper Circuit | ₹1,071.10 |
| Lower Circuit | ₹714.10 |
Shilpa Medicare Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹8,814.87 Cr
Return on Equity (ROE)
1.59
PE Ratio (TTM)
112.39
Return on capital employed (ROCE)
2.77
Industry PE ratio
56.12
Beta (LTM)
1.28
P/B Ratio
1.87
Dividend Yield
0PEG Ratio
25.9
Quarterly Earnings Growth YOY
-40.78
EPS (TTM)
3.68
Sector
Pharmaceuticals
Book Value
208.37
Technical Analysis
Bullish
View Technical Analysis
How to invest in Shilpa Medicare?
Investing in Shilpa Medicare is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Shilpa Medicare or SHILPAMED on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Shilpa Medicare or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Shilpa Medicare with just a few clicks!
Shilpa Medicare Stock's Interest Amongst Investors
Shilpa Medicare Valuation
Track how the P/E of Shilpa Medicare has moved over time to understand valuation trends.
Shilpa Medicare in the last 5 years
Lowest (-6579.29x)
March 28, 2024
Industry (56.12x)
May 30, 2025
Today (112.39x)
May 30, 2025
Highest (503.73x)
February 21, 2023
Today’s Price to Earnings Ratio: 112.39x
Analysts Recommendation on Shilpa Medicare
Get updated buy, sell, and hold recommendations by analysts on Shilpa Medicare.
based on 2 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Shilpa Medicare. Average target price of ₹1191
Source: S&P Global Market Intelligence
Analysts Forecast on Shilpa Medicare
Get share price movements and forecasts by analysts on Shilpa Medicare.
Shilpa Medicare price forecast by 2 analysts
Upside of32.13%
High
₹1525
Target
₹1191.00
Low
₹857
Shilpa Medicare target price ₹1191, a slight upside of 32.13% compared to current price of ₹901.4. According to 2 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Shilpa Medicare revenue growth forecast
Expected growth rate Q1, FY2027:0
Forecast
Actual
Including amortisation and stock based compensations
Shilpa Medicare EPS growth forecast
EPS estimate Q1, FY2027:0
Forecast
Actual
Source: S&P Global Market Intelligence
Shilpa Medicare Financials
Get the annual and quarterly financial summary of Shilpa Medicare, including revenue, profit, loss and more.
Shilpa Medicare Index Inclusions
Shilpa Medicare Earnings and Dividends
View detailed summary of the earnings and dividend history of Shilpa Medicare.
Shilpa Medicare Ltd Earnings Results
Shilpa Medicare Ltd’s net profit fell -40.78% since last year same period to ₹14.51Cr in the Q4 2024-2025. On a quarterly growth basis, Shilpa Medicare Ltd has generated -54.34% fall in its net profits since last 3-months.
Read More about Earnings ResultsShilpa Medicare Ltd Dividends May,2022
In the quarter ending March 2022, Shilpa Medicare Ltd has declared dividend of ₹1.10 - translating a dividend yield of 0.24%.
Read More about Dividends
Shilpa Medicare Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Shilpa Medicare.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 44.23% | 0.00 | |
| Foreign Institutions | 10.97% | 0.00 | |
| Mutual Funds | 4.05% | 0.00 | |
| Retail Investors | 37.25% | 0.00 | |
| Others | 3.5% | 0.00 |
Shilpa Medicare vs Peers
Compare market cap, revenue, PE, and other key metrics of Shilpa Medicare with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 8,814.87 | 25.8% | 0.53 | NA | NA | |
| BUY | 26,670.77 | 114.11% | 0.52 | NA | NA | |
| BUY | 18,698.63 | 38.27% | 0.57 | NA | NA | |
| NA | 6,008.52 | 6.86% | 0.79 | NA | NA | |
| BUY | 14,242.62 | 42.31% | 0.68 | NA | NA |
Shilpa Medicare News & Key Events
Latest news and events at one place to help you take investing decisions in Shilpa Medicare.
Antique Cuts Target Price for Shilpa Medicare - 28 May, 2025
Antique Broking maintains a 'Buy' rating on Shilpa Medicare but lowers the target price to ₹1,090 due to regulatory delays and cost pressures. Despite a strong Q4FY25 revenue growth of 13%, the firm has cut revenue estimates for FY26/27 and adjusted EBITDA margin assumptions. However, it remains optimistic about the long-term monetization potential of Shilpa's product pipeline.Shilpa Medicare Reports Q4 Losses and Future Prospects - 27 May, 2025
Shilpa Medicare reported a 41% decline in net profit for Q4 FY25, despite a revenue increase. Analysts see potential in upcoming product launches. The company declared a Rs 1 dividend per share for FY 2024-2025.Shilpa Medicare Partners with Orion for Albumin Distribution - 23 May, 2025
Shilpa Medicare's subsidiary, Shilpa Biocare, has entered a strategic partnership with Orion Corporation to distribute Recombinant Human Albumin in Europe, enhancing market access and safety.Shilpa Medicare Shares Surge on USFDA Approval - 15 May, 2025
Shilpa Medicare's shares increased by nearly 5% following the receipt of an Establishment Inspection Report (EIR) from the USFDA for its Unit-1 facility, classified as Voluntary Action Indicated (VAI). The company also secured European GMP accreditation for its biologics unit, enhancing its regulatory standing.Shilpa Medicare Secures EMA GMP Certification - 06 May, 2025
Shilpa Medicare's Unit VI in Bengaluru has received Good Manufacturing Practice (GMP) approval from the European Medicines Agency, enhancing its ability to market innovative drug delivery systems in the EU.Shilpa Medicare Secures EU GMP Certification - 05 May, 2025
Shilpa Medicare's subsidiary, Shilpa Biologics, has obtained European GMP certification for its Dharwad plant, allowing the production of test batches following a successful inspection by Austrian authorities.
Insights on Shilpa Medicare Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 320.79 Cr → 340.68 Cr (in ₹), with an average increase of 5.8% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, SHILPAMED has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 9.90% to 10.97% in Mar 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, SHILPAMED stock has moved up by 14.0%
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 44.23% of holdings in Mar 2025 quarter
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 119.1% return, outperforming this stock by 15.3%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 31.78 Cr → 14.51 Cr (in ₹), with an average decrease of 54.3% per quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 4.89% to 4.05% in Mar 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 37.60% to 37.25% in Mar 2025 quarter
About Shilpa Medicare
Revenue: ₹330.80Cr as on March 2025 (Q4 FY25)
Net Profit: ₹14.51Cr as on March 2025 (Q4 FY25)
Listing date: 03 Dec, 2009
Chairperson Name: Omprakash Inani
| Organisation | Shilpa Medicare Ltd |
| Industry | Pharmaceuticals |
| CEO | Omprakash Inani |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Shilpa Medicare
Check out the Mutual Funds with significant holdings in Shilpa Medicare.
FAQs
What is Shilpa Medicare share price today?
Shilpa Medicare share price today stands at ₹901.4, Open: ₹892.1, Previous Close: ₹892.6, High: ₹924.2, Low: ₹889.2, 52 Week High: ₹959.5, 52 Week Low: ₹417.6.
What is today's traded volume of Shilpa Medicare?
Today's traded volume of Shilpa Medicare is 5.79L. Which means that 5.79L shares of Shilpa Medicare were bought and sold on the stock market during today's trading session.
What is Shilpa Medicare's market cap today?
Today's market capitalisation of Shilpa Medicare is ₹8,814.87 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Shilpa Medicare?
Shilpa Medicare’s 52 week high is ₹959.5 and 52 week low is ₹417.6. The current share price of Shilpa Medicare is ₹901.4, which is -6.06% down from its 52 week high and 115.85% up from its 52 week low.